• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性动脉闭塞性疾病中的血液流动性和凝血现象。

Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.

作者信息

Angelkort B, Boateng K, Maurin N

出版信息

J Int Med Res. 1980;8(3):242-6. doi: 10.1177/030006058000800310.

DOI:10.1177/030006058000800310
PMID:7389992
Abstract

Blood fluidity depends on a number of factors of which especially the deformability of erythrocytes is of importance. Investigations reported in this paper have revealed an interdependence between blood fluidity and coagulability of blood. They confirm the significance of maintaining red cells deformability if an adequate microcirculation is to be provided in patients with occlusive vascular disease. High doses of oral pentoxifylline are able to improve erythrocyte flow rates in patients with occlusive vascular disorder. This agent also decreases platelet hyper-reactivity, a factor of importance in arresting the arteriosclerotic progression. In addition the hypercoagulability existing in such patients is reduced and the fibrinolytic system stimulated by treatment with the drug.

摘要

血液流动性取决于多种因素,其中红细胞的可变形性尤为重要。本文报道的研究揭示了血液流动性与血液凝固性之间的相互依存关系。这些研究证实,对于患有闭塞性血管疾病的患者,若要提供充足的微循环,维持红细胞的可变形性具有重要意义。高剂量口服己酮可可碱能够改善患有闭塞性血管疾病患者的红细胞流速。该药物还能降低血小板的高反应性,这是阻止动脉粥样硬化进展的一个重要因素。此外,此类患者存在的高凝状态会因该药物治疗而降低,且纤溶系统会受到刺激。

相似文献

1
Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.慢性动脉闭塞性疾病中的血液流动性和凝血现象。
J Int Med Res. 1980;8(3):242-6. doi: 10.1177/030006058000800310.
2
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
Scand J Clin Lab Invest Suppl. 1981;156:185-8. doi: 10.3109/00365518109097457.
3
Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.抗血栓形成作用在慢性动脉闭塞性疾病药物治疗中的意义。
Ric Clin Lab. 1981;11 Suppl 1:215-21.
4
[Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].[慢性动脉闭塞性疾病中的血小板功能、血浆凝血及纤维蛋白溶解。己酮可可碱研究]
Med Welt. 1979 Aug 24;30(34):1239-43.
5
Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
Curr Med Res Opin. 1979;6(4):255-8. doi: 10.1185/03007997909109432.
6
The effect of pentoxifylline on the flow properties of human blood.
Curr Med Res Opin. 1978;5(8):608-13. doi: 10.1185/03007997809110195.
7
Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Angiology. 1976 Mar;27(3):188-96. doi: 10.1177/000331977602700306.
8
The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
J Med. 1979;10(5):331-8.
9
Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Angiology. 1985 Sep;36(9):628-37. doi: 10.1177/000331978503600907.
10
Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.己酮可可碱治疗周围阻塞性动脉疾病的临床药理学及疗效研究。
Angiology. 1984 Jul;35(7):427-35. doi: 10.1177/000331978403500705.